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Abstract
Lectins are non-immunoglobulin carbohydrate-binding proteins without enzymatic activity
towards the bound carbohydrates. Many lectins of e.g. plants or fungi have been suggested
to act as toxins to defend the host against predators and parasites. We have previously
shown that the Coprinopsis cinerea lectin 2 (CCL2), which binds to α1,3-fucosylated N-gly-
can cores, is toxic to Caenorhabditis elegans and results in developmental delay and pre-
mature death. In this study, we investigated the underlying toxicity phenotype at the cellular
level by electron and confocal microscopy. We found that CCL2 directly binds to the intesti-
nal apical surface and leads to a highly damaged brush border with loss of microvilli, actin
filament depolymerization, and invaginations of the intestinal apical plasma membrane
through gaps in the terminal web. We excluded several possible toxicity mechanisms such
as internalization and pore-formation, suggesting that CCL2 acts directly on intestinal apical
plasma membrane or glycocalyx proteins. A genetic screen for C. elegansmutants resistant
to CCL2 generated over a dozen new alleles in bre 1, ger 1, and fut 1, three genes required
for the synthesis of the sugar moiety recognized by CCL2. CCL2-induced intestinal brush
border defects in C. elegans are similar to the damage observed previously in rats after
feeding the dietary lectins wheat germ agglutinin or concanavalin A. The evolutionary con-
served reaction of the brush border between mammals and nematodes might allow C. ele-
gans to be exploited as model organism for the study of dietary lectin-induced intestinal
pathology in mammals.
Introduction
Lectins are carbohydrate-binding proteins without enzymatic activity towards the bound car-
bohydrates and are of non-immunoglobulin origin [1]. Apart from diverse internal biological
functions in plants, fungi, and animals [1–3], lectins have also been suggested to act as toxins
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to defend against predators and parasites, likely explaining the observed toxicity of some lectins
against various organisms [4,5]. A particular example of such toxins are the dietary lectins,
found for example in grain and legumes, which are toxic to humans [6]. For example, the
wheat germ agglutinin (WGA) binds to and damages the brush border (microvilli and glycoca-
lyx at the intestinal apical surface [7]) of the intestinal epithelium in mammals [8,9].
Lectins can exert their toxicity in various ways. Some lectins induce toxicity by carbohydrate
binding only [10,11], either acting at the membrane directly [12] or sometimes following endo-
cytosis [13]. Other lectins possess an additional domain with enzymatic activity that interferes
with cell function. For example, ricin inactivates ribosomes [14],Marasmius oreades agglutinin
(MOA) degrades crucial internal proteins by its cysteine protease activity [15], while the Laeti-
porus sulphureus lectin (LSL) is an exotoxin that binds to and induces pores at the cell surface
[16]. However, for many lectins, the actual molecular mechanism of toxicity remains unknown,
even when the bound sugar moiety (glycotarget) and / or the structure of the lectin are known.
The nematode Caenorhabditis elegans has been extensively used as a model system to study
infection and toxicity mechanisms. C. elegans can be infected with diverse pathogens such as
bacteria, fungi, microsporidia or viruses [17–19], which can kill it by diverse strategies includ-
ing colonization, persistent infection or invasion of the intestine, biofilm formation, or through
the action of toxins such as the pore-forming crystal proteins of Bacillus thuringiensis [20,21].
In C. elegans, pathogens mainly target the intestine or the cuticle / hypoderm. The resulting in-
testinal disease phenotypes range from lumenal distention, lumenal colonization by bacteria,
damaged apical plasma membrane to cell lysis [17,22].
C. elegans has also been used to study the mechanisms of toxicity of various molecules, in-
cluding pharmacological agents, heavy metals, and lectins [23,24]. We previously reported that
the fungal lectin Coprinopsis cinerea lectin 2 (CCL2) is toxic when fed to C. elegans. CCL2
binds to glycoproteins carrying an α1,3-fucosylated N-glycan core [10]. Biosynthesis of this
glycotarget occurs via conversion of GDP-mannose to GDP-fucose by BRE-1 and GER-1 [10],
followed by transfer of this fucose to the proximal and distal N-acetylglucosamine (GlcNAc)
residues of the N-glycan core by the α1,3-fucosyltransferases FUT-1 and FUT-6, respectively
[25]. Complete loss of fucose by mutations in bre-1 or ger-1 prevents CCL2 binding and there-
fore conveys complete resistance to CCL2 ([10] and see below). Failure to attach the proximal
fucose by mutations in fut-1 leads to partial resistance, whereas failure to attach the distal fu-
cose by mutations in fut-6 still allows for toxicity by binding of CCL2 to the proximal fucose.
Complete resistance is achieved in the fut-6 fut-1 double mutant. CCL2 only has a single carbo-
hydrate-binding site and no known enzymatic activity [10]. Upon feeding to C. elegans, CCL2
causes developmental delay and premature death [10]; the underlying cytopathology has how-
ever not been investigated yet.
Here we present a detailed characterization of the CCL2 toxicity phenotype in C. elegans.
We found that CCL2 binds to the brush border of the intestinal epithelium, leading to dramatic
morphological changes within hours, including loss of microvilli, invaginations of the intestinal
apical plasma membrane and gaps in the terminal web. Interestingly, the structural defects in-
duced by CCL2 are very similar to those observed at the mammalian intestinal brush border
following exposure to dietary lectins such as WGA or concanavalin A (Con A) [9]. In our
model organism, the disorganization of the brush border is likely the underlying cause for the
observed intestinal malfunction, developmental delay, and premature death. We could exclude
known toxicity mechanisms such as lectin internalization or pore formation in the intestinal
apical plasma membrane, suggesting that CCL2 exerts its toxicity in a novel way directly at the
cell surface. Given the similarity of the observed phenotypes in worms and mammals, C. ele-
gans could possibly be a good model to better understand the cellular and molecular intestinal
pathology induced by dietary lectins in mammals.
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Results
Exposure of C. elegans to the fungal lectin CCL2 leads to delayed
development, an enlarged intestinal lumen, and premature death
To assess the effect of CCL2 exposure on development, wild-type C. elegans embryos were left
to hatch and develop on plates seeded with Escherichia coli BL21(DE3) expressing either CCL2
or the empty vector (pet24) as a negative control (Fig 1). Animals raised on control plates
reached the L4 stage approximately 44 h post-hatching, whereas CCL2-fed worms only reached
the L2 stage during this time (Fig 1A). Worms exposed to CCL2 did eventually reach adulthood
on day 7, but looked sick, pale, and produced only few progeny before succumbing approxi-
mately 2 days later (3 days post-L4). CCL2 is also toxic to animals exposed at later develop-
mental stages: whereas wild-type L4 larvae fed on control E. coli for 24 h matured into fertile
adults, L4 animals fed on CCL2-expressing E. coli developed into thin, small, pale, sick young
adults that had not yet laid any eggs (Fig 1B). Differential Interference Contrast (DIC)
Fig 1. CCL2 exposure to C. elegans results in delayed development and enlargement of the intestinal
lumen. (A) Wild-type C. elegans fed on control (empty vector) E. coli reached the L4 larval stage 44 h after
hatching, whereas worms fed on CCL2-expressing E. coli only reached larval stage L2 (stereo microscopy).
(B,C) Wild-type L4 larvae kept on control or CCL2-expressing E. coli for 24 h. The detectable developmental
delay was evident already after 24 h (B; stereo microscopy). CCL2 also caused an enlarged intestinal lumen
in these larvae (C; DIC microscopy). Scale bar: 0.5 mm (A-B), 20 μm (C); inset: 2x magnification of the
lumenal section of the intestine.
doi:10.1371/journal.pone.0129381.g001
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microscopy of CCL2-treated animals revealed a meandering and enlarged intestinal lumen
(Fig 1C and S1A Fig). The condition of these animals worsened over time: only few progeny
were produced and the animals started dying 3 days post-L4. We conclude that chronic expo-
sure of C. elegans to CCL2 causes delayed development, a distended intestinal lumen, reduced
brood size, and premature death.
CCL2 binds to and alters the brush border of the intestine without being
internalized
To identify the possible site of action of CCL2, we fed purified red fluorescently labeled recom-
binant CCL2 protein (CCL2-TAMRA (tetramethylrhodamine)) to C. elegans L4 larvae express-
ing PGP-1::GFP [26], an ATP-binding cassette (ABC) transporter that localizes to and marks
the intestinal apical plasma membrane (Fig 2 and S1B Fig). CCL2-TAMRA at a non-toxic
concentration (100 μg/ml) colocalized with PGP-1::GFP after 24 h, indicating binding of CCL2
at the apical surface (glycocalyx or plasma membrane) of the intestine (Fig 2A and S1B Fig).
To determine whether CCL2 was internalized after binding, we also performed a time course
experiment using a toxic concentration (500 μg/ml) of CCL2-TAMRA. At all time points,
CCL2-TAMRA was confined to the intestinal lumen, showing that CCL2 was not taken up by
intestinal cells. After 1 and 3 h, CCL2 bound to the intestinal apical surface without any signs
of toxicity (Fig 2B and 2C), whereas after 24 h, the intestinal lumen was distended and the plas-
ma membrane deformed (Fig 2D, inset). Taken together, these observations suggest that bind-
ing of CCL2 to the C. elegans intestinal apical surface is sufficient to cause the developmental
delay and the changes observed at the intestinal apical plasma membrane.
Exposure to CCL2 results in loss of microvilli, deformation of the
intestinal apical plasma membrane, and gaps in the terminal web
To analyze the impact of CCL2 binding on the intestinal apical plasma membrane at ultrastruc-
tural level, wild-type C. elegans L4 larvae were analyzed using transmission electron microsco-
py (TEM) (Fig 3). Control animals showed the typical intestinal brush border morphology
(S1B Fig) consisting of a dense brush border of microvilli (Fig 3A, asterisk) surrounded by a
glycocalyx (Fig 3C, arrow) and stabilized by the terminal web, a network of actin and interme-
diate filaments running below and in parallel to the apical plasma membrane ([27]; Fig 3C, ar-
rowhead). By contrast, in animals fed 24 h on CCL2-expressing E. coli, the intestinal brush
border was highly disordered: many microvilli were lost (Fig 3B, asterisks) and the plasma
membrane previously surrounding these microvilli formed invaginations into the cytoplasm
(Fig 3B, arrows), penetrating through large gaps in the terminal web (Fig 3B, arrowheads).
Structures resembling detached microvilli and other debris were visible in the intestinal lumen
(Fig 3D, arrow and S2A Fig, open arrows). Unlike the apical surface, the baso-lateral surface
between neighboring cells, including the adherens junctions, appeared normal (Fig 3F, open
arrow and arrowhead and S1B Fig).
To reconstruct the microvilli in three dimensions, we performed focused ion beam scanning
electron microscopy (FIB-SEM) on wild-type L4 larvae fed for 24 h on control (empty vector)
or CCL2-expressing E. coli. In control-fed worms, the microvilli of the dense brush border
neatly aligned and were equal in length (Fig 3E and S1 Video). By contrast, the brush border of
CCL2-fed animals was highly disorganized. Microvilli also occasionally fused to each other,
building coral-reef like structures (Fig 3F, filled arrow and S2 Video).
To determine the kinetics of apical structure destruction, we analyzed animals treated with
CCL2-expressing E. coli for 3 and 6 h. Invaginations were visible already after 3 h (Fig 3G, ar-
rows). After 6 h on CCL2-expressing E. coli, the invaginations had increased in number and
Disruption of Gut Microvilli inC. elegans by CCL2
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size (Fig 3H, filled arrows) and penetrated through gaps in the terminal web (Fig 3H, filled ar-
rowheads). Often, the invaginations appeared as detached big vesicle-like structures but they
were always connected with the plasma membrane at another focal plane (based on FIB-SEM
z-stack analysis). In some microvilli, the stabilizing actin filament bundles were depolymerized
(Fig 3H, asterisks); these microvilli also lost the dark cap normally visible at their tip (Fig 3H,
Fig 2. CCL2 binds to and alters the brush border of the intestine without being internalized. (A-D) C. elegans L4 larvae expressing PGP-1::GFP were
fed with a non-toxic (100 μg/ml; A) or toxic (500 μg/ml; B-D) concentration of CCL2-TAMRA (tetramethylrhodamine: red) for the indicated hours and observed
using confocal microscopy. (A) CCL2-TAMRA colocalized with PGP-1::GFP at the apical intestinal plasmamembrane. (B-D) Toxic concentrations of
CCL2-TAMRA led to a time-dependent alteration of the brush border without any detectable uptake into intestinal cells. Scale bar: 10 μm; inset: 2x
magnification of the lumenal section of the intestine.
doi:10.1371/journal.pone.0129381.g002
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Fig 3. CCL2 leads to microvilli loss, intestinal plasmamembrane invaginations, and terminal web
gaps.Wild-typeC. elegans L4 larvae were fed on control (empty vector) (A,C,E) or CCL2-expressing E. coli
(B,D,F-H) for the indicated hours and then observed under a transmission (A-D, G,H) or focused ion beam
scanning electron microscope (E,F). (A,C) The intestinal apical surface of control animals showed the typical
dense brush border made of microvilli (asterisk) and glycocalyx (arrow), and an intact terminal web
(arrowhead) underlying the intestinal apical plasmamembrane. (B,D) Exposure to CCL2 prompts missing
microvilli (asterisks); invaginations of intestinal apical plasmamembrane filled with lumenal content (arrows);
and disruption of the terminal web (arrowheads). (E,F) 3D reconstruction of selected microvilli in control (E)
and CCL2-treated (F) animals showing the disorganized brush border following CCL2 exposure; fused
microvilli (yellow; filled arrow); cell border (open arrow); adherens junction (arrowhead). (G,H) Morphological
changes are already visible at the ultrastructural level after 3 h (G) and 6 h (H) of exposure to CCL2;
invaginations of plasmamembrane (filled arrows); terminal web (filled arrowheads); dark cap at the tip of
microvilli (open arrows); intact actin filament bundles (open arrowheads); depolymerized actin filament
bundles (asterisks). Scale bar: 500 nm.
doi:10.1371/journal.pone.0129381.g003
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open arrows and S2B Fig, arrows). These results indicate that a few hours of exposure to CCL2
are sufficient to cause large-scale structural damage to the intestinal brush border.
To confirm the structural changes observed by electron microscopy in living animals, we
fed CCL2 to C. elegans strains expressing fluorescent fusion proteins labeling various subcellu-
lar structures of the intestine (Fig 4). We first analyzed the effect of CCL2 on the intestinal
apical plasma membrane using PGP-1::GFP. While GFP expression at the apical plasma mem-
brane was detectable as a continuous straight line flanking a thin intestinal lumen in control
animals, the plasma membrane in CCL2-treated worms was deformed and featured “dark
spots” (Fig 4A), which presumably correspond to the invaginations that we observed with elec-
tron microscopy (Fig 3). Apical membrane deformations and invaginations could also be ob-
served with a RAB-8::GFP reporter [26], which is involved in protein trafficking and labels the
intestinal cytoplasm (Fig 4B and S1B Fig). We followed the loss of microvilli using ERM-1::
GFP [28] and ACT-5::GFP [29] reporter strains. The ERM-1 protein links the actin filaments
in the microvilli to the intestinal apical plasma membrane (S1B Fig); ACT-5 is the major con-
stituent of the actin filaments found in the microvilli and in the terminal web (S1B Fig). In con-
trol animals, the brush border was so dense that at the confocal level both ERM-1 and ACT-5
were visible as thin continuous lines. Upon exposure to CCL2, both the ERM-1::GFP and the
ACT-5::GFP lines were frequently interrupted, presumably due to the loss of microvilli (Fig 4C
and 4D). To determine the extent of terminal web gaps, we exposed a C. elegans IFB-2::CFP
line [30] to CCL2. IFB-2 is an intermediate filament that is part of the terminal web (S1B Fig).
On control E. coli, the terminal web was visible as two straight, compact, parallel lines framing
the intestinal lumen. By contrast, CCL2-treated worms showed many interruptions in these
lines (Fig 4E), confirming the presence of gaps in the terminal web.
Taken together, our results show that exposure to CCL2 leads to a deformed intestinal apical
plasma membrane, loss of microvilli, and gaps in the underlying terminal web.
CCL2 does not induce pore formation in the intestinal apical plasma
membrane
How does exposure to CCL2 result in the numerous intestinal defects described above? Some
toxins, such as members of the Cry protein family of B. thuringiensis, are known to disrupt in-
testinal function through generation of pores in the intestinal apical plasma membrane [21].
To test whether CCL2 also induces pore formation, C. elegans L4 larvae expressing PGP-1::
GFP were grown on control (empty vector pQE30), Cry21A- (a known pore-forming toxin
[31]) or CCL2-expressing E. coli for 24 h, followed by a 2 h exposure to propidium iodide
(red), which can enter and stain intestinal cells when pores are present in the plasma mem-
brane [32] (Fig 5). In control animals, propidium iodide was restricted to the lumen (Fig 5A),
whereas in Cry21A-fed worms, propidium iodide was localized in the cytoplasm, confirming
its pore-forming activity (Fig 5B). In CCL2-fed animals, propidium iodide was confined to the
intestinal lumen, suggesting that the plasma membrane, in spite of its obvious deformation,
maintained its integrity (Fig 5C). That CCL2 and the pore-forming crystal proteins of B. thur-
ingiensis have distinct molecular modes of action is also suggested by the observation that they
induce significantly different sets of morphological defects at the intestinal brush border, both
at the cellular and ultrastructural level (Figs 3 and 5 and [32]).
Exposure to CCL2 leads to a rapid decrease in dipeptides and increase
in fatty acids
Morphological signs of toxicity were visible already after 3 h of exposure to CCL2 (Fig 3G). To
identify early molecular markers of CCL2 intoxication, and possibly gain insight into to the
Disruption of Gut Microvilli inC. elegans by CCL2
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Fig 4. CCL2 alters the structure of the intestinal brush border and terminal web in living animals. (A-E) C. elegans L4 larvae of the indicated genotype
were fed for 24 h on control (empty vector) or CCL2-expressing E. coli. Various fluorescent transgenic reporters were used to detect changes in intestinal cell
Disruption of Gut Microvilli inC. elegans by CCL2
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mechanism of CCL2 action, we performed a metabolomic study on wild-type and on bre-1
(ye4) (resistant to CCL2 [10]) L4 larvae exposed for 3 h either to wild-type CCL2 or to a carbo-
hydrate-binding deficient, non-toxic CCL2 variant (CCL2M; see Materials and Methods) (S3
Fig). Out of 280 metabolic compounds quantified, 101 (36%) showed a significant change
(p0.05) in wild-type C. elegans following exposure to CCL2 (S1 Table), suggesting a dramatic
change in the animal’s metabolism. Striking changes included a significant reduction in the
abundance of most dipeptides (55/71, 77%; S3A Fig and S1 Table), whereas a large fraction of
free fatty acids (10/28, 36%) and lysophospholipids (6/25; 24%) were increased in abundance
(S3B Fig and S1 Table). Both changes were specifically associated with CCL2 toxicity, as neither
was observed in CCL2-fed bre-1(ye4)mutants.
architecture by confocal microscopy. (A) PGP-1::GFP is expressed at the intestinal apical plasmamembrane. (B) RAB-8::GFP labels the intestinal
cytoplasm. (C) ERM-1::GFP links the intestinal apical plasmamembrane to the actin filaments within the microvilli. (D) ACT-5::GFP labels actin filaments
within the microvilli and the terminal web underlying the intestinal apical plasmamembrane. (E) IFB-2::CFP labels intermediate filaments in the terminal web.
Scale bar: 10 μm; inset: 2x magnification of the lumenal section of the intestine.
doi:10.1371/journal.pone.0129381.g004
Fig 5. CCL2 does not induce pore formation in the intestinal apical plasmamembrane. (A-C) C. elegans L4 larvae expressing PGP-1::GFP were fed on
control (empty vector pQE30) (A), Cry21A- (B) or CCL2- (C) expressing E. coli for 24 h, transferred into wells containing propidium iodide (PI; red) for 2 h and
observed using confocal microscopy. Cry21A is a pore-forming toxin of B. thuringiensis [31]. PI entered the intestinal cytoplasm of Cry21A-fed (B), but not of
control- (A) or CCL2- (C) fed animals. Scale bar: 10 μm.
doi:10.1371/journal.pone.0129381.g005
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Consistent with our prior phenotypic analyses [10], bre-1(ye4)mutants were fully resistant
to CCL2 treatment also at a metabolomic level: only 11 out of 280 metabolic compounds
showed changes at a significance level of p0.05, and none at p0.01 (S1 Table). Somewhat
surprisingly, bre-1(ye4) itself also had only a very weak overall impact on the C. elegansmeta-
bolome. Only 23 compounds showed alterations between the wild type and bre-1mutants at a
significance level of p0.05, and only three at p0.01, which is close to the expected false dis-
covery rate (S1 Table).
In summary, our metabolomic analysis shows that exposure to CCL2 rapidly gives rise to
extensive changes in intestinal metabolism in wild-type animals, and confirms the full resis-
tance to toxicity conferred by the loss of BRE-1 function.
CCL2 is not toxic in the absence of bacteria
In all experiments described so far, CCL2 was always administered to C. elegans together with
bacteria as a food source (either E. coli BL21(DE3) on plates, or Bacillus subtilis in liquid cul-
ture; see Materials and Methods). Many bacterial species, including E. coli, are to various de-
grees toxic to C. elegans [20]. To find out if bacteria might directly or indirectly contribute to
the CCL2 toxicity mechanism, we exposed L4 larvae expressing PGP-1::GFP for 24 h to CCL2
in the presence or absence of bacteria (Fig 6). Whereas simultaneous administration of
CCL2-TAMRA and B. subtilis led to the characteristic intestinal defects described above (Figs
2D and 6B), treatment with CCL2-TAMRA in the absence of bacteria failed to induce any plas-
ma membrane alterations (Fig 6D), suggesting that the presence of bacteria is required for
CCL2 toxicity.
Bacteria could contribute directly to CCL2 toxicity, e.g. through synergic or additive damage
to the intestinal brush border. Alternatively, bacteria might simply be needed as a food source,
e.g. to ensure a high degree of intestinal cell metabolic activity, which might sensitize the intes-
tine to CCL2 action. We tried to distinguish between these two hypotheses by exposing C. ele-
gans to CCL2 under axenic (bacteria-free) growth conditions (S4 Fig). Exposure of PGP-1::
GFP L4 larvae to CCL2-TAMRA for 24 h in axenic medium failed to induce any change in in-
testinal apical membrane morphology (S4C Fig), indicating that CCL2 is not toxic under these
conditions. However, axenic medium is far from optimal as a food source and generally leads
to slow growth [33], which might not be sufficient to support CCL2 toxicity. For example, we
found that PGP-1::GFP L1 larvae grown for 3 days in axenic medium only reached the L2
stage, whereas they would readily reach L4 stage and adulthood when fed bacteria. L4 larvae
fed with axenic medium for 24 h were also slower in their development to adults. It is thus not
yet possible to definitively exclude the “bacteria as food” model, and further experiments will
be necessary to determine the exact role of bacteria in CCL2-mediated toxicity.
Reduced expression of ACT-5 induces a phenotype similar to CCL2
We showed above that exposure to CCL2 leads to altered fluorescence patterns of many intesti-
nal apical surface proteins (Fig 4). These changes could simply be markers of CCL2 toxicity. Al-
ternatively, some of the observed phenotypes could be the result of the direct inactivation and /
or mislocalization of one or several of these proteins by a CCL2-triggered toxicity pathway. For
example, we showed that ACT-5::GFP is relocalized upon exposure to CCL2 (Fig 4D), that
some ACT-5 actin filament bundles depolymerized in the microvilli (Fig 3H), and that the
actin filament containing terminal web is discontinuous (Fig 3). Thus, interference with ACT-
5 function might induce the CCL2 toxicity phenotype in C. elegans.
To address this issue, we asked whether we could phenocopy the toxicity of CCL2 by
performing RNAi-mediated knockdown of act-5 (S5 Fig). C. elegans L1 larvae expressing
Disruption of Gut Microvilli inC. elegans by CCL2
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PGP-1::GFP growing on E. coli expressing act-5 double-stranded RNA (dsRNA) arrested at the
L2 stage. If put as L4 larvae on E. coli expressing act-5 dsRNA, animals started showing overt
signs of sickness (small, pale adults with poor fertility) after 48 h. By confocal microscopy,
changes in the intestinal apical membrane were visible after 24 h. The lining of the intestinal
apical plasma membrane was still present but the membrane formed “bubbles” towards the cy-
toplasm (S5 Fig). Exposure to CCL2 led to a similar adult phenotype but their development to
reach adulthood was not arrested, only delayed. At confocal microscopy level, the whole intes-
tinal apical plasma membrane was affected (Fig 4A). We conclude that interference with ACT-
5 function might contribute, but cannot be the sole cause of CCL2 toxicity.
Intestinal expression of α1,3-fucose modified N-glycan cores is sufficient
for toxicity of CCL2
We showed above that binding of CCL2 to the intestinal apical surface results in toxicity (Fig
2). We previously demonstrated that CCL2 recognizes a fucosylated N-glycan core structure
Fig 6. CCL2 is not toxic in the absence of bacteria. (A-D)C. elegans L4 larvae expressing PGP-1::GFP were exposed to the indicated TAMRA-labeled
protein (red; BSA (bovine serum albumin); B-D) for 24 h in the presence (A,B) or absence (C,D) of B. subtilis and observed using confocal microscopy. Only
the combination of CCL2-TAMRA and B. subtilis led to toxicity (B). Scale bar: 10 μm; inset: 2x magnification of the lumenal section of the intestine; n/
a = not applicable.
doi:10.1371/journal.pone.0129381.g006
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([10,25]; Fig 7A). It is thus likely that CCL2 induces toxicity through its binding to one or sev-
eral proteins that carry this sugar structure and that are localized on the intestinal apical sur-
face. In an effort to identify this / these protein(s), or any other molecule involved in
CCL2-mediated toxicity, we performed mutagenesis screens with the transposonMos1 and
with the chemical ethyl methanesulfonate (EMS) on wild-type C. elegans. F2 progenies of ran-
domly mutagenized worms were let to hatch on plates seeded with CCL2-expressing E. coli and
resistant mutants were recovered. All fourteen isolated mutations affected the previously iden-
tified resistance genes bre-1 (9 alleles), ger-1 (3 alleles; [34,35]), or fut-1 (2 alleles) (Fig 7B).
These results confirm the importance of the proximal α1,3-fucose on the N-glycan cores for
CCL2 toxicity.
Since CCL2 binds its glycotarget at the apical surface of the intestine (Fig 2), we wanted to
test if expression of bre-1, ger-1, and fut-1 in the intestine alone would be sufficient to confer
sensitivity to CCL2. To this aim, we constructed transgenic C. elegans strains expressing the
three wild-type genes in the intestine only (using the gut-specific ges-1 promoter) in the respec-
tive mutant background (bre-1(ye4); ger-1(op499); fut-1(ok892)). As expected, all three trans-
genes restored sensitivity to CCL2 (Fig 7C).
Taken together, our data indicate that interaction between CCL2 and its fucosylated glyco-
target, which is found on one or several proteins present on the intestinal apical surface, is suf-
ficient to induce a broad range of morphological and functional defects ultimately resulting in
premature death.
Discussion
In this work, we describe the detailed pathology induced in C. elegans by CCL2, a fungal lectin
that causes toxicity solely through its ability to bind to its glycotarget(s) on the intestinal apical
surface. Exposure to CCL2 leads to loss of microvilli, shedding of microvilli fragments into the
lumen, actin depolymerization, and invaginations of the plasma membrane previously sur-
rounding the microvilli through gaps in the terminal web. Overall, the intestine of C. elegans is
faced with a destabilized and fragmented brush border and terminal web, resulting in greatly
disturbed digestion / nutrient uptake, and consequently delayed development, reduced brood
size, and premature death.
What is the mechanism of CCL2 toxicity? Our experiments ruled out many of the known
ways in which lectins can cause cellular damage. The 15 kDa CCL2 consists only of a single car-
bohydrate-binding domain and has no known enzymatic activity [10], is not internalized by in-
testinal cells (Fig 2), and does not induce pore formation (Fig 5). There were also no signs of
endocytosis of the PGP-1::GFP stained plasma membrane (Fig 4A) as can be observed follow-
ing intoxication with pore-forming toxins [32]. Finally, there was no loss in intestinal polarity
upon exposure to CCL2, since the transmembrane protein PGP-1::GFP was still exclusively ex-
pressed on the apical surface of the intestine after 24 h (Fig 4A). Since several toxicity mecha-
nisms could be excluded for CCL2, we propose that CCL2 employs a novel mode of action.
Exposure to CCL2 highly disturbed the metabolism of C. elegans. The most striking changes
were a reduction in the abundance of dipeptides and an increase in fatty acids. Dipeptides are
produced in the intestinal lumen by hydrolysis of bacterial proteins and taken up by C. elegans
intestinal cells via e.g. the PEPT/OPT H+-coupled oligopeptide transporter family [36,37]. A
reduction in overall dipeptide abundance could be the result of a disturbed intestinal function–
either from a decreased degradation of proteins into dipeptides in the intestinal lumen, or from
decreased dipeptide uptake into the intestinal cells, prompting their eventual loss through defe-
cation. The increase in free fatty acids and in lysophospholipids could be the result of either al-
tered degradation or uptake of bacterial lipids, or of an increased degradation of endogenous C.
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Fig 7. Intestinal expression of α1,3-fucosylated N-glycan cores is sufficient for toxicity of CCL2. (A) Structure of the C. elegansCCL2 core glycotarget
[10,25]. (B) Alleles conferring resistance to CCL2 recovered after transposon (Mos1)- or EMSmutagenesis. (Chr.: chromosome; Mutation: base pair change
and its position (position 1: “A” of start codon ATG) in the genomic sequence as well as the resulting amino acid change. (C) Intestinal expression of wild-type
bre-1, ger-1, or fut-1 in the respective C. elegansmutant was sufficient to restore sensitivity to CCL2. All constructs were under the control of the intestinal
promoter ges-1 and C-terminally tagged withmCherry (red). Transgenic and control animals were grown on CCL2-expressing E. coli for 3 days. Data shown
are average ± standard error of the mean of three experiments. Asterisks (*): After 3 days, all worms were L2 larvae.
doi:10.1371/journal.pone.0129381.g007
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elegans lipids. We consider the latter hypothesis more likely, as we also observed increased con-
centrations of lysophospholipids deriving from phosphatidylcholine (2/8) and phosphatidyli-
nositol (2/4) (together: 4/12; 33%; S1 Table), which are not found in bacteria and thus must be
of C. elegans origin [38]. The increased phospholipid degradation might be an early sign of the
large-scale plasma membrane loss that is observable a few hours later.
Interestingly, bacteria are required for CCL2 to be toxic (Fig 6). A similar requirement has
previously been reported for B. thuringiensis-mediated insecticidal activity and for dietary lec-
tins [39,40], whereas e.g. Pseudomonas aeruginosa PA14 produces diffusible toxins that are
also toxic in the absence of bacteria [41]. The contribution of bacteria to CCL2 toxicity is un-
clear. Both gram-negative (E. coli) and gram-positive bacteria (B. subtilis) enable CCL2 toxicity,
suggesting a general or evolutionary conserved mechanism. Live bacteria in the intestine of C.
elegans are not required for CCL2 toxicity since no intact bacteria were observed in the intesti-
nal lumen. Bacterial enzymes or other cellular components might be actively involved in CCL2
toxicity. They might be needed to unmask the CCL2 glycotarget [42] or to damage the plasma
membrane. Indeed, Miyake et al. reported that lectins were only toxic to cell cultures upon arti-
ficial membrane damage [43]. A functional plasma membrane repair mechanism and an active
immune system have to be in place to fight naturally occurring damage by intestinal bacteria
[43–45]. CCL2 could negatively regulate either of them, e.g. by hindering exocytosis of new
membrane patches or repolymerization of actin filaments or by blocking receptors of endoge-
nous lectins involved in innate immunity [43,44,46]. Alternatively, bacterial components could
have a mere passive function in CCL2 toxicity, e.g. by stimulating endo- and exocytosis as part
of digestion, which might lead, together with the action of CCL2, to a loss of homeostasis at the
intestinal plasma membrane. In any case, CCL2 does not seem to be a primary “toxin”.
How does CCL2 act at the molecular level? The binding of CCL2 to protein targets in the
glycocalyx or on the intestinal apical plasma membrane could prompt the activation or inacti-
vation of (a) signaling pathway(s) that then disrupt(s) directly or indirectly the structural integ-
rity of the brush border. The fact that the bre-1, ger-1, and fut-1 C. elegansmutants are healthy
despite the lack of GDP-fucose [47] suggests either that CCL2 does not inhibit a pathway, or
that the pathway inhibited by CCL2 can be activated by its endogenous ligand independent of
fucose-binding. Rather than affecting a signaling pathway, CCL2 might, through binding to its
target, interfere with and disturb the network of glycoproteins that make up the glycocalyx
[48]. This in turn might destabilize the microvilli embedded in the glycocalyx and result in
their progressive loss. In addition, or as an alternative, disturbance of the glycocalyx network
could allow bacterial or endogenous enzymes access to the plasma membrane and damage it
[7].
One way for CCL2 to exert its toxicity might be by affecting the function of proteins that are
compounds of microvilli or the terminal web (S1B Fig). Knockdown or knockout of the genes
coding for these proteins might thus potentially phenocopy CCL2 toxicity. Even though knock-
down or knockout of act-5, eps-8, erm-1, and several intermediate filaments do affect brush
border and terminal web structures [27,30,49–51], none of their phenotypes at the fluorescence
or TEMmicroscopy level was similar to what we observed with CCL2, with the exception of
knockdown of act-5, which can induce terminal web gaps [19]. However, knockdown of act-5
on PGP-1::GFP expressing worms only partially reproduced the plasma membrane changes
observed following CCL2 treatment (S5 Fig and Fig 4A). Thus, interference with ACT-5 func-
tion might contribute to the CCL2 toxicity pattern but it seems unlikely to be the sole cause.
To identify the protein(s) carrying the glycotarget and / or additional components involved
in CCL2 toxicity, we performed several genetic screens for C. elegansmutants resistant to
CCL2 toxicity. However, the only resistance genes that we could identify were the previously
characterized enzymes involved in the production and addition of the proximal fucose onto
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the N-glycan core (Fig 7A and 7B). This suggests that we have saturated the universe of single
genes that confer, through simple loss of function, resistance to CCL2 without interfering with
animal viability. We conclude that the CCL2 targets, as well as other proteins involved in the
toxicity mechanism, are likely either redundant or essential. Other approaches, such as bio-
chemical purification of CCL2-interacting proteins, will thus be required to identify the pro-
teins directly targeted by CCL2.
Previous studies have characterized the effect of various bacterial and microsporidial patho-
gens as well as lectins on the intestine by TEM [19,22,32,40]. Although some of these also led
to loss of microvilli, the overall phenotype of the brush border was always clearly different
from the one after CCL2 exposure. Strikingly, and by contrast, the CCL2 phenotype is quite
similar to the one observed in mammalian brush border cells following exposure to the dietary
lectins WGA or Con A, which also lead to depolymerization of microvilli and invaginations of
the intestinal plasma membrane [9]. That lectins can elicit similar cellular pathologies in spe-
cies as distant as worms and mammals suggests that despite the considerable difference in
gross anatomy, the cellular anatomy and physiology of the intestinal brush border is highly
conserved between C. elegans and mammals. Thus, C. elegansmight be a promising model or-
ganism to study pathologies, such as exposure to dietary lectins, that affect intestinal brush bor-
der function in mammals.
Materials and Methods
Strains
C. elegans and bacterial strains used in this study are listed in S2 Table.
Recombinant and purified CCL2 from C. cinerea
CCL2 isolation, purification, and expression in the pet24b vector (Novagen, Merck KGaA,
Darmstadt, Germany) in E. coli BL21(DE3), as well as generation and purification of His8-
tagged CCL2 was performed as described [10]. CCL2 and BSA were TAMRA-labeled (Molecu-
lar Probes, Life Technologies, Carlsbad, USA) as described [52].
C. elegans culturing conditions
All C. elegans strains were maintained at 20°C on nematode growth media (NGM) agar plates
seeded with E. coli OP50 [53] with the following exceptions: E. coli BL21(DE3) was used to ex-
press recombinant CCL2; E. coli JM109(DE) was used to express Cry21A; E. coliHT115(DE3)
was used to express dsRNA for RNAi; B. subtilis was used for liquid cultures.
Toxicity assays on plates with unlabeled recombinant CCL2
NGM agar plates containing isopropyl β-D-1-thiogalactopyranoside (IPTG; 2 mM) to induce
expression of the bacterial plasmid, and kanamycin (0.1 mM) to avoid bacterial contamination,
were seeded with an overnight culture of E. coli BL21(DE3) strains (Novagen) containing the
pet24b plasmid with CCL2 (toxicity) or without CCL2 (empty vector; control) in lysogeny
broth (LB) [53]. As positive control for the pore-forming assay, the pore-forming toxin
Cry21A (crystal protein) of B. thuringiensis [31] and its empty vector pQE30 expressed in E.
coli JM109(DE3) were grown on NGM agar plates containing IPTG (1 mM) and ampicillin
(0.3 mM).
For the developmental assay, adult C. elegans worms were bleached [53] and the embryos
left to hatch on plates seeded with the appropriate bacteria (day 1). After 44 h, images were
taken or the number of worms reaching the L4 larval stage was determined. For the L4 assay,
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C. elegans L4 larvae were grown for 24 h on plates seeded with the appropriate bacteria, fol-
lowed by microscopic analysis. For the pore-forming assay, the worms were transferred, prior
to analysis, for 2 h to 96-well plates containing propidium iodide (6.7 μg/ml) and S-medium
only [32,53].
Toxicity assays in liquid medium with purified CCL2-TAMRA
All assays were done in S-medium in a total volume of 50 μl per well in 96-well plates. Approxi-
mately 15 C. elegans L4 larvae and, if indicated, 5 μl of a bacterial overnight culture concentrat-
ed to OD600 = 20, and purified CCL2-TAMRA or BSA-TAMRA were added to each well. For
the CCL2 binding assay, the worms were incubated with non-toxic concentrations of
CCL2-TAMRA (100 μg/ml) and E. coli BL21(DE3) empty vector as food. After 24 h, the
worms were let to crawl on plates seeded with E. coli BL21(DE3) empty vector for 2 h to wash
out unbound CCL2-TAMRA. For the internalization assay, the worms were incubated with
toxic concentrations of CCL2-TAMRA (500 μg/ml) and B. subtilis as food because unlike E.
coli this species does not agglutinate in the presence of high concentrations (500 μg/ml) of
purified CCL2. After 1, 3, or 24 h, worms were transferred onto B. subtilis-seeded plates for 1 h
to remove unbound CCL2-TAMRA, followed by microscopic analysis. For the toxicity assay
without bacteria, worms grown to the L4 stage on E. coli OP50-seeded plates were washed 6
times with M9 buffer [53] to remove the bacteria. Approximately 15 L4 larvae / 20 μl S-medi-
um (M9 buffer was replaced by S-medium) were transferred into each well. The worms were
incubated for 24 h in wells containing B. subtilis or no bacteria and / or CCL2-TAMRA
(500 μg/ml) or BSA-TAMRA (500 μg/ml). For the toxicity assay with axenic medium, the axe-
nic medium was derived from Castelein et al., 2008 [54] and contained: S-medium; 2.4% (w/v)
soy-peptone; 2.4% (w/v) dry yeast extract; 0.5 mg/ml hemoglobin; 5 μg/ml cholesterol; 0.1 mg/
ml ampicillin. The worms were incubated for 24 h in wells containing axenic medium or B.
subtilis and / or CCL2-TAMRA (500 μg/ml). All assays were analyzed by confocal microscopy.
Microscopy of C. elegans
Dissection microscopy images were taken with a stereo microscope Leica MZ 12.5 equipped
with a Nikon Coolpix 990 digital camera. For DIC and fluorescence microscopy, worms were
placed on 3% agarose pads in a drop of 10 mM levamisole for anesthesia and mounted under a
coverslip. DIC images were taken using a Leica DM6000B microscope equipped with DIC
(Nomarski) optics, a PL Fluotar 40x/1.00–0.50NA Oil objective, a Leica DFC360FX camera,
and the LAS AF Leica Application Suite software (version 2.6.0.7266; Leica Microsystems, Vi-
enna, Austria). Fluorescence images were taken using a Carl Zeiss LSM710 confocal micro-
scope equipped with a Plan-Apochromat 63x/1.40NA Oil DIC M27 objective and the Zen2009
software (Zeiss, Oberkochen, Germany). Images were false-colored by ImageJ. For transmis-
sion electron microscopy (TEM) and focused-ion beam scanning electron microscopy (FIB-
SEM), worms were frozen in a HPM 100 high-pressure freezing machine (Leica Microsystems).
After freeze-substitution, samples were block stained with 1% uranyl acetate in acetone (stock
solution: 20% in methanol) for 1 h at 4°C and embedded in Epon / Araldite (Sigma-Aldrich,
St. Louis, USA). Thin sections were post-stained with Reynolds lead citrate and analyzed at
80 kV acceleration voltage using a CM100 transmission electron microscope (FEI, Eindhoven,
The Netherlands) equipped with a side mounted digital camera Orius 1000 (Gatan, Munich,
Germany). For FIB-SEM, ion milling with an advance of 5 nm per image and image acquisition
were performed simultaneously in an Auriga 40 Crossbeam system (Zeiss, Oberkochen, Ger-
many) using the FIBICS Nanopatterning engine (Fibics Inc., Ottawa, Canada). SEM images
were acquired at 1.7 kV using an in-lens energy selective backscattered electron detector (ESB)
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with a grid voltage of 1.4 kV, and a dwell time of 35 or 40 μs. The pixel size was set to 5 nm and
tilt-corrected to obtain isotropic voxels. Alignment of the image stack was performed with the
Sift plugin [55] of the ImageJ image-processing package [56]. Segmentation of microvilli was
done with Imaris (Bitplane AG, Zurich, Switzerland) using the surpass surface tool. For more
details, consult the supporting information (S1 Text).
Metabolomics
Wild-type and bre-1(ye4) C. elegans L4 larvae were transferred for 3 h to plates seeded with E.
coli expressing wild-type CCL2 or mutated, non-toxic CCL2 (CCL2M; amino acid (aa) change
in carbohydrate-binding part: G230A(bp)! G77E(aa)) as negative control; created by PCR-
based site-directed mutagenesis (Thermo Scientific, Thermo Fisher Scientific, Waltham,
USA)). The worms were collected with phosphate-buffered saline (PBS) buffer, immediately
frozen in liquid nitrogen, and subsequently analyzed by Metabolon (www.metabolon.com,
Durham, USA). Samples were extracted and prepared for analysis using Metabolon’s standard
solvent extraction method. The extracted samples were split into equal parts for analysis on the
gas chromatography–mass spectrometry (GC-MS) and liquid chromatography–tandem mass
spectrometry (LC-MS/MS) platforms. Also included were several technical replicate samples
created from a homogeneous pool containing a small amount of all study samples (“Client
Matrix”). Metabolon’s general platform methods are described in [57]. Statistical terminology:
q-values: to account for the multiple testing problem, the p-values were adjusted using an opti-
mized false discovery rate approach [58].
RNA interference (RNAi) assay
Feeding RNAi bacteria was performed as described [59]. In short, E. coliHT115(DE3) [60] ex-
pressing act-5 dsRNA from vector L4440 (Ahringer RNAi library) were incubated overnight in
LB containing ampicillin (0.6 mM) and tetracycline (0.03 mM) and then seeded on NGM agar
plates containing ampicillin (0.6 mM) and IPTG (2 mM). Worms expressing PGP-1::GFP were
either let to hatch or transferred as L4 larvae onto the RNAi plates (day 1). In both cases
worms were followed for 6 days.
Screen for CCL2 resistant C. elegans strains by EMS andMos1
mutagenesis
EMS (ethyl methanesulfonate) mutagenesis was performed with wild-type C. elegans (N2) as
described [61]. Approximately 40,000 haploid genomes were screened. Adult F1 progeny of
EMS treated P0 were bleached [53] and distributed onto CCL2-expressing E. coli plates, and
the F2 generation was screened for CCL2-resistant worms. Mutations were mapped to chromo-
somes using fragment-length polymorphisms (FLP) mapping Tier 1 [62]. As all mutations
mapped to chromosomes II, III, and IV, which also carry the fut-1, ger-1, and bre-1 genes, re-
spectively, we PCR amplified and sequenced the genome locus (exons and introns) of the rele-
vant candidate gene for each mutant. For op570, the mutation was only found after whole
genome sequencing, which was prepared and performed according to [63]. For six mutations
(op561, op565, op566, op568, op570, op577), complementation tests [64] and FLP mapping Tier
2 were performed to increase the confidence that the mutation found by sequencing is respon-
sible for the resistance phenotype.
TheMos1 transposon insertional mutagenesis was performed with C. elegans strains mutat-
ed in pmk-1(km25) as described [65]. Approximately 200,000 haploid genomes were screened.
Two of the three recovered resistant mutants lost theMos1 transposon but remained resistant
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as the loss ofMos1 left a footprint behind, which was identified analogously to the EMS
mutants.
Construction of transgenic worms
The 5’ (1504bp upstream of ATG) and 3’ (1989bp downstream of TAA) regulatory regions of
ges-1 were used to drive the intestinal expression of wild-type bre-1, ger-1, and fut-1. For all
three genes, the genomic wild-type sequence from the start codon to one codon before the stop
codon were fused tomCherry (red) at their 3’ end by conventional restriction digest and liga-
tion. The three parts (5’ and 3’ regions of ges-1 and gene fused tomCherry) were fused by Gate-
way recombination (Life Technologies, Carlsbad, USA) and cloned into competent bacteria for
sequencing and DNA extraction. The transgenic worms were created by micro particle bom-
bardment [66] and crossed into the respective mutant strain (bre-1(ye4); ger-1(op499); fut-1
(ok892)).
Accession numbers
Accession numbers for C. elegans genes and gene products mentioned in this paper are based
onWormbase (http://www.wormbase.org). pgp-1 (K08E7.9), rab-8 (D1037.4), erm-1
(C01G8.5), act-5 (T25C8.2), ifb-2 (F10C1.7), bre-1 (C53B4.7), ger-1 (R01H2.5), fut-1
(K08F8.3), fut-6 (T05A7.5), ges-1 (R12A1.4). The complementary DNA (cDNA) sequence of
CCL2 from C. cinerea strain AmutBmut was deposited in GenBank (accession number
ACD88750).
Supporting Information
S1 Fig. Schematic representation of C. elegans and an intestinal cell. (A) Scheme of an adult
C. elegans. Figure modified from Kaletta and Hengartner, 2006 [67]. The intestine of C. elegans
has only 20 non-renewable polarized epithelial cells that form the intestinal tube in nine rings
of two directly apposed cells, except for the first ring that is formed by four cells [7]. (B) Scheme
of an intestinal cell. The brush border consists of microvilli and a glycocalyx that covers the
apical surface of intestinal cells. Microvilli are finger-like protrusions of the intestinal plasma
membrane that increase the absorptive surface. Figure modified fromMcGhee [7].
(TIF)
S2 Fig. Microvillar debris in the intestinal lumen after exposure to CCL2.Wild-type C. ele-
gans L4 larvae were fed on CCL2-expressing (A) or control (B) E. coli for 24 h and observed
under a transmission electron microscope. (A) The intestinal lumen is filled with debris. On
one side of the brush border, the microvilli are cut in cross-section (filled arrow). Similar struc-
tures, possibly microvillar remnants, can be observed floating in the lumen (open arrows). (B)
Dark cap (arrows) and actin filament bundles (arrowheads) are visible in intact microvilli.
Scale bar: 500 nm.
(TIF)
S3 Fig. CCL2 results in decreased dipeptides and increased free fatty acids.Wild-type (wt)
and bre-1(ye4) (bre-1; resistant to CCL2 [10]) C. elegans L4 larvae were fed on control (mutat-
ed, non-toxic CCL2 (CCL2(G77E) = CCL2M)) or wild-type CCL2-expressing E. coli for 3 h
and were thereafter checked for changes in the abundance of various metabolites. CCL2 treat-
ment led to a decrease in dipeptide (A) and an increase in free fatty acid (B) concentrations.
Only two representative molecules are shown for each group.
(TIF)
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S4 Fig. CCL2 is not toxic to worms fed on axenic medium. (A-C) C. elegans L4 larvae ex-
pressing PGP-1::GFP were fed with axenic medium (A, C) or B. subtilis (B) together with
CCL2-TAMRA (red) (B, C) and observed using confocal microscopy. Only the combination of
CCL2-TAMRA and B. subtilis induced toxicity (B). Scale bar: 10 μm; inset: 2x magnification of
the lumenal section of the intestine; n/a = not applicable.
(TIF)
S5 Fig. act-5(RNAi) also alters the intestinal apical plasma membrane. C. elegans L4 larvae
expressing PGP-1::GFP were fed for 24 h with E. coli expressing act-5 dsRNA. Reduced ACT-5
abundance gave rise to a disturbed intestinal apical plasma membrane, in which the lining was
still visible but “bubbles” were formed towards the cytoplasm. Two representative images are
shown. Scale bar: 10 μm; inset: 2x magnification of the lumenal section of the intestine.
(TIF)
S1 Table. Metabolomic profile following CCL2 treatment.Mean values: Black-bolded text
indicates samples chosen for S3 Fig. Fold change: Molecules showing a statistically significant
change (p0.05) are highlighted: increased abundance, red; decreased abundance, green. q-val-
ues (false discovery rate adjusted p-values) give estimates of the false discovery rate. All data
are normalized to Bradford protein concentration values.
(XLSX)
S2 Table. Bacterial and C. elegans strains used in this study.
(DOCX)
S1 Text. Transmission and FIB scanning electron microscopy. Detailed protocol.
(DOCX)
S1 Video. FIB-SEM z-stack and 3D reconstruction of selected microvilli. Exposure of wild-
type L4 larvae to control E. coli for 24 h.
(MP4)
S2 Video. FIB-SEM z-stack and 3D reconstruction of selected microvilli. Exposure of wild-
type L4 larvae to CCL2-expressing E. coli for 24 h.
(M4V)
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